Volume 26, Issue 3 - Observational Studies

RCTs: Can the treatment work? Patient registries: Does the treatment work?

Author: Maria Kołtowska-Häggström

Abstract

Download the full article

References

1. Altman DG. What randomized trials and systematic reviews can offer decision makers. Horm Res 1999;51(suppl 1): 36–43. Available from: http://
2. Carter MJ, Fife CE, Walker D, Thomson B. Estimating the applicability of wound care randomized controlled trials to general wound-care populations by estimating the percentage of individuals excluded from a typical wound-care population in such trials. Adv Skin Wound Care 2009;22:316– 24. 3. Available from: http://
3. Gliklich R, Dreyer N, Leavy M, editors. Registries for evaluating patient outcomes: a user’s guide. 3rd ed. Two volumes. AHRQ Publication No. 13(14)-EHC111. Rockville, MD: Agency for Healthcare Research and Quality. April 2014. Available from: https://effectivehealthcare.ahrq.gov/topics/registries-guide-3rd-edition/research/
4. Smith GCS, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. Br Med J 2003;327:1459–61. Available from: http://
5. Atkins D, Best D, Briss PA et al. Grading quality of evidence and strength of recommendations. Br Med J 2004;328:1490. Available from: http://
6. Gattrell WT, Hopewell S, Young K et al. Professional medical writing support and the quality of randomised controlled trial reporting: a cross-sectional study Br Med J Open 2016;6:e010329. doi:10.1136/bmjopen-2015-010329. Available from: http://
7. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP for the STROBE Initiative; The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008;61:344–9. Available from: http://
8. Odeyemi IAO, Dakin HA, O’Donnell RA, Warner J, Jacobs A, Dasgupta P. Epidemiology, prescribing patterns and resource use associated with overactive bladder in UK primary care. Int J Clin Pract 2006;60:949–58. Available from: http://
9. Mo D, Fleseriu M, Qi R et al. Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study. Lancet Does it work? How does it work in real life? Patient registries answer these questions. www.emwa.org Volume 26 Number 3 | Medical Writing September 2017 | 11 Diabetes Endocrinol 2015;3:331–8. 10. Available from: http://
10. Tritos NA, Johannsson G, Korbonits M et al. Effects of long-term growth hormone replacement in adults with growth hormone deficiency following cure of acromegaly: a KIMS analysis. J Clin Endocrinol Metab 2014; 99(6):2018–29. Available from: http://
11. Kołtowska–Häggström M, Mattsson AF, Monson JP et al. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life? Eur J Endocrinol 2006;155:109–19. Available from: http://
12. Reinehr T, Lindberg A, Koltowska– Haggstrom M, Ranke M. Is growth hormone treatment in children associated with weight gain? Longitudinal analysis of KIGS data. Clin Endocrinol 2014;81: 721–6. Available from: http://
13. Vandenbroucke JP, von Elm E, Altman DG et al, for the STROBE initiative. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Ann Intern Med 2007;147:W-163–W-194. Available from: http://
14. Abs R, Feldt-Rasmussen U, Mattsson AF et al. Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults – a KIMS database analysis. Eur J Endocrinol 2006;155:79–90. Available from: http://